STOCK TITAN

Axiom Intelligence (AXIN) eyes Nasdaq listing for Terra Quantum at $3.5B valuation

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
425

Rhea-AI Filing Summary

Axiom Intelligence Acquisition Corp 1 disclosed a proposed business combination with Terra Quantum AG, noting a reported $3.5 billion valuation and plans for a Nasdaq listing in the second half of the year. Axiom intends to file a Registration Statement on Form F-4 and will mail a definitive proxy statement/prospectus to its stockholders when available.

The communication includes standard forward-looking statements and a detailed list of risks that could affect the timing or completion of the transaction, including SEC review, shareholder approval, legal proceedings, integration risks, and the ability to meet Nasdaq listing standards.

Positive

  • None.

Negative

  • None.

Insights

SPAC merger disclosure highlights valuation target and U.S. listing plan.

The filing states a $3.5 billion valuation for Terra Quantum and an intention to pursue a Nasdaq listing in the second half of the year, with a Registration Statement on Form F-4 to be filed. The disclosure frames the U.S. listing as a capital and valuation rationale.

Key dependencies include SEC review of the Registration Statement and Axiom stockholder approval; timing hinges on regulatory review and customary closing conditions. Subsequent filings will provide definitive terms and shareholder vote details.

Standard integration and regulatory risks are disclosed; proxy/prospectus forthcoming.

The communication contains customary forward-looking statements and an extensive risk list, including potential SEC objection to the Form F-4, litigation risk, and a requirement for Axiom stockholder approval. It also identifies costs and integration risks tied to consummation.

Watch for the filed Registration Statement and the definitive proxy statement/prospectus for material terms, conditions to closing, and any negotiated deal protections; those documents will determine regulatory and shareholder pathways.

Valuation $3.5 billion reported valuation for Terra Quantum
Target listing window second half of the year intended Nasdaq listing timing stated in the communication
Registration form Form F-4 Registration Statement to be filed with the SEC
Proxy distribution definitive proxy statement/prospectus to be mailed to Axiom stockholders as of a record date
Registration Statement on Form F-4 regulatory
"the U.S. Securities and Exchange Commission ("SEC") may object to the registration statement on Form F-4"
A registration statement on Form F-4 is a regulatory filing used when a foreign company offers or issues securities in connection with a merger, acquisition, exchange offer or similar transaction that involves U.S. securities law. It gathers the deal terms, financial statements, management background and risk factors into one disclosure package so investors can evaluate the transaction — like an ingredient list and instruction manual investors read before deciding to buy or vote on the new or exchanged shares.
proxy statement/prospectus regulatory
"The definitive proxy statement/prospectus will be mailed to stockholders"
A proxy statement or prospectus is a document that companies send to shareholders to provide important information about upcoming decisions or investments, such as voting on company issues or offering new shares to the public. It helps investors understand the details and risks involved, enabling them to make informed choices about their ownership or involvement with the company.
forward-looking statements financial
"This communication contains "forward-looking statements" within the meaning of "safe harbor" provisions"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Nasdaq listing standards regulatory
"ability of the combined company to meet the Nasdaq Stock Market's listing standards"
Nasdaq listing standards are the set of rules a company must meet to be admitted to and remain on the Nasdaq stock market, covering financial thresholds (like minimum share price and earnings), reporting and disclosure, and board and governance practices. They matter to investors because meeting these standards signals a baseline of financial health and transparency, reduces the risk of sudden delisting, and helps ensure a market with enough buyers and sellers—like a safety checklist that keeps the trading venue orderly and trustworthy.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

Filed by Axiom Intelligence Acquisition Corp 1

Pursuant to Rule 425 under the Securities Act of 1933

And deemed filed pursuant to Rule 14a-12

Under the Securities Exchange Act of 1934

Subject Company: Axiom Intelligence Acquisition Corp 1

(Commission File No. 001-42708)

 

LinkedIn Post

 

3.5 billion dollar valuation. German technology. Nasdaq instead of Frankfurt.

 

This news should give pause for thought. In a conversation with ntv Nachrichten, Markus Pflitsch explains why Terra Quantum AG wants to go public in the U.S. in the second half of the year: More capital. Higher valuations. Greater openness to innovation.

 

This is more than a stock-exchange decision. It is a signal about Europe as a business location. While Germany debates AI, robotics, and quantum computing, many of the most innovative technology companies are seeking their growth capital in the United States.

 

How do we expect to become technology leaders if our future-oriented companies have to go to America for their next stage of development?

 

FORWARD-LOOKING STATEMENTS

 

This communication contains “forward-looking statements” within the meaning of “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “believe,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “project,” “target,” “outlook,” “may,” “will,” “would,” “could,” “should,” or other similar words and expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding the proposed business combination, including the anticipated timing and benefits of the transaction, Terra Quantum AG’s (“Terra Quantum” or the “Company”) future growth, financial performance, business strategy, market opportunities, and competitive position.

 

These forward-looking statements are based on current expectations, estimates, forecasts, and projections, as well as the beliefs and assumptions of management as of the date of this communication, and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (i) the occurrence of any event, change, or other circumstances that could give rise to the termination of the business combination agreement by and between Axiom Intelligence Acquisition Corp 1 (“Axiom”) and Terra Quantum (the “Business Combination Agreement”); (ii) the outcome of any legal proceedings that may be instituted against Axiom or Terra Quantum or their respective directors or officers following the announcement of the proposed business combination; (iii) the inability to complete the proposed business combination due to the failure to obtain approval of the stockholders of Axiom or other conditions to closing in the Business Combination Agreement; (iv) the occurrence of any event, change, or other circumstance that could give rise to the failure to consummate the proposed business combination, including the risk that the U.S. Securities and Exchange Commission (“SEC”) may object to the registration statement on Form F-4 (the “Registration Statement”); (v) the receipt of an unsolicited offer from another party for an alternative business transaction that could interfere with the proposed business combination; (vi) the risk that the proposed business combination disrupts current plans and operations of Axiom or Terra Quantum as a result of the announcement and consummation of the proposed business combination; (vii) costs related to the proposed business combination; (viii) changes in applicable laws or regulations; (ix) the possibility that Axiom, Terra Quantum, or the combined company may be adversely affected by other economic, business, and/or competitive factors; (x) the ability of the combined company to meet the Nasdaq Stock Market’s listing standards following the consummation of the proposed business combination; (xi) the inability to realize the anticipated benefits of the proposed business combination, including due to failure to successfully integrate the businesses; (xii) risks related to the uncertainty of the projected financial information with respect to Terra Quantum; (xiii) risks related to Terra Quantum’s ability to develop, commercialize, and scale its quantum computing, quantum security, and AI-driven optimization solutions; (xiv) risks related to the emerging and evolving nature of the quantum technology industry, including uncertainty regarding market adoption, technological feasibility, and customer demand; (xv) risks related to Terra Quantum’s ability to protect and maintain its intellectual property and proprietary technology; (xvi) risks related to rapid technological change, competition, and evolving industry standards; (xvii) risks related to reliance on key personnel, scientific talent, strategic partners, and third-party infrastructure providers; and (xviii) other risks and uncertainties described in Axiom’s filings with the SEC, including under the heading “Risk Factors” in Axiom’s Annual Report on Form 10-K and subsequent filings with the SEC.

 

 

 

Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Neither Axiom nor Terra Quantum undertakes any duty to update these forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.

 

Additional Information and Where to Find It

 

This communication is for informational purposes only and is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy, any securities or the solicitation of any vote in any jurisdiction pursuant to the proposed transactions or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

 

In connection with the proposed business combination, Axiom intends to file a Registration Statement with the SEC that will include a proxy statement/prospectus relating to the proposed business combination. INVESTORS AND STOCKHOLDERS OF AXIOM ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED BUSINESS COMBINATION. The definitive proxy statement/prospectus will be mailed to stockholders of Axiom as of a record date to be established for voting on the proposed business combination and related matters.

 

Investors and stockholders will be able to obtain free copies of the Registration Statement and the proxy statement/prospectus (when available) and other documents containing important information about Axiom, Terra Quantum, and the proposed business combination, once such documents are filed with the SEC, through the website maintained by the SEC at www.sec.gov. Investors and stockholders may also obtain copies of the documents filed with the SEC by Axiom free of charge by directing a written request to: Axiom Intelligence Acquisition Corp 1, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009 Cayman Islands, Attention: Richard Dodd, Executive Chairman / Doug Ward, Chief Executive Officer, or by visiting Axiom’s website at https://www.aiac1.com/.

 

Participants in the Solicitation

 

Axiom, Terra Quantum, and their respective directors and executive officers may be deemed participants in the solicitation of proxies from the stockholders of Axiom in connection with the proposed business combination. Investors and stockholders may obtain more detailed information regarding the names, affiliations, and interests of Axiom’s directors and executive officers in Axiom’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on March 25, 2026, and in subsequent filings with the SEC, including the proxy statement/prospectus relating to the proposed business combination when it becomes available.

 

Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies to Axiom’s stockholders in connection with the proposed business combination, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement/prospectus when it is filed with the SEC. Information regarding Axiom’s directors and executive officers is contained in its filings with the SEC.

 

No Offer or Solicitation

 

This communication relates to the proposed transaction and is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy any securities or the solicitation of any vote in any jurisdiction pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom, and otherwise in accordance with applicable law.

 

 

 

FAQ

What valuation is mentioned for Terra Quantum in the Axiom (AXIN) communication?

The communication references a $3.5 billion valuation for Terra Quantum. This figure appears in the disclosed announcement as the cited valuation metric for the proposed transaction.

When does Terra Quantum plan to list on Nasdaq according to the filing?

The filing states an intent to pursue a Nasdaq listing in the second half of the year. Timing is described as a target and remains subject to regulatory approvals and closing conditions.

What SEC filing will Axiom submit for the proposed business combination?

Axiom intends to file a Registration Statement on Form F-4 that will include the proxy statement/prospectus relating to the proposed business combination with Terra Quantum.

Will Axiom mail a proxy statement to its stockholders?

Yes. The communication states the definitive proxy statement/prospectus will be mailed to Axiom stockholders as of a record date established for voting on the proposed business combination.

What major risks does the communication highlight for the transaction?

The filing lists risks including SEC review of the Registration Statement, requirement for Axiom stockholder approval, potential litigation, integration challenges, costs, and meeting Nasdaq listing standards.